MedTrace Logo

Retrospective Evaluation of Clinical, Virological and Serological Data in Patients With Mild Acute Upper Respiratory Tract Infections

NCT05134766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2021-11-26

No results posted yet for this study

Summary

Retrospective analysis with subgroup evaluation

Primary objectives of the data analysis study:

1 Retrospective analysis of the symptoms and quality of life data of patients with mild, acute (\<96 hours) upper respiratory symptoms based on the results of standard health assessment questionnaires used at the institution, over a period of 10-15 days after the SARS CoV-2 PCR test.

Secondary objectives

1 Retrospective assessment of the upper respiratory tract symptoms and quality of life and serological parameters of the contact persons with confirmed close exposure to SARS CoV-2 PCR positive patients (based on the results of the standard health assessment questionnaires used at the institution in the period of 10-15 days after the SARS CoV-2 PCR test)

The retrospective analysis also includes an assessment of the pharmacological and supplementary therapies used in patients presenting with mild, acute (\<96 hours) upper respiratory symptoms and SARS CoV-2 positive contacts, as well as the incidence of SARS CoV-2 virus infection in contacts confirmed by PCR test (based on values measured within 48 hours and 10-15 days later), and an analysis of patients' serological data.

Conditions

  • Acute Upper Respiratory Tract Infection

Interventions

OTHER

Observation only

Based on type of SOC applied and the type of CAM products by subject's own decison

Sponsors & Collaborators

  • Herb-Pharma Sk, s.r.o.

    collaborator UNKNOWN

  • Medix Clinical & Academic Research Consulting

    collaborator UNKNOWN

  • Complex Medical Centre Deli Klinika

    lead OTHER

Principal Investigators

  • Botond Lakatos, MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05134766 on ClinicalTrials.gov